Charter Communications Sweetens Terms in Buyout Deal for Liberty Broadband LEDS Q1 2026 Earnings EPS Loss of 007 as Company Continues Strategic Realignment Replimune Secures FDA Agreement on Melanoma Drug Resubmission Path